The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Jyothy Labs Limited is an India-based fast-moving consumer goods (FMCG) company. The Company manufactures and markets a variety of products, such as fabric care, household insecticides, personal care, and dishwashing products catering to a diverse range of consumer needs and…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A high-quality, fast-growing business, trading cheap versus its own history.
Jyothy Labs is scored on the consumer / fmcg framework. It keeps a healthy 12.8% of every rupee of sales as net profit. Cash broadly tracks reported profit (CFO/PAT 0.84×). Free cash flow is worth about 2.1% of its market value.
Over the last 3 years revenue compounded at 9%/yr and profit at 33%/yr. Book value has grown 14%/yr. Return on equity is an elite 19.2%. In the latest quarter profit fell 13% versus the prior quarter.
At 20× earnings, the stock sits at the 5th percentile of its own 4.6-year range — the cheap end of where it has historically traded. Today's price implies ~16%/yr earnings growth for a decade. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 32.57 | 34.31 | better |
| P/B | 5.89 | 7 | better |
| EV/EBITDA | 21.76 | 24.55 | better |
| ROE | 19.2 | 12.73 | better |
| ROCE | 23.85 | 20.49 | better |
| ROA | 16.8 | 10.05 | better |
| Quick Ratio | 2.12 | 8.7 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Hindustan Unilever | 31.1 | 9.6 | 22.9% |
| ITC | 18.4 | 5.0 | 26.4% |
| Nestle India | 60.5 | 42.7 | 70.6% |
Revenue has grown every year across all 4 financial years shown. 9% CAGR — growing but slowly. Growth is decelerating — latest year grew slower than the year before.
Profit is on a 2-year growth streak. Profit is growing faster than revenue (33% vs 9%) — margin expansion is at work.
Operating margin has expanded from 9% to 17% — the business is keeping more of each rupee earned. The gap between operating and net margin is widening — interest or tax costs are rising.
ROE at 18% — a respectable return on shareholder capital. Capital efficiency improving — ROE up 7pp across the window.
32% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Heavy investing spend every year, but operations generate enough to cover it — the business self-funds its growth. Financing outflows in consecutive years — balance-sheet discipline through debt repayment or dividends.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue broadly flat QoQ — stable but not accelerating. Low quarterly variance (10% spread) — a predictable, non-seasonal revenue stream.
Profit fell 13% QoQ — one-quarter drops can be noise, but a pattern matters. Quarterly margins are compressing (13% → 11%) — more revenue isn't translating to proportionally more profit.
How today's P/E compares to the stock's own historical range. Dashed line = the 4.6y median.
Promoter holding at 62.9% — majority control intact. MF stake down 5.7pp — domestic funds are booking profits or rebalancing out.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.